Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064190%3A_____%2F21%3AN0000134" target="_blank" >RIV/00064190:_____/21:N0000134 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/21:10421083
Result on the web
<a href="https://onlinelibrary.wiley.com/doi/10.1111/all.14295" target="_blank" >https://onlinelibrary.wiley.com/doi/10.1111/all.14295</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/all.14295" target="_blank" >10.1111/all.14295</a>
Alternative languages
Result language
angličtina
Original language name
Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I
Original language description
Eicosanoids are biologically active lipid mediators, comprising prostaglandins, leukotrienes, thromboxanes, and lipoxins, involved in several pathophysiological processes relevant to asthma, allergies, and allied diseases. Prostaglandins and leukotrienes are the most studied eicosanoids and established inducers of airway pathophysiology including bronchoconstriction and airway inflammation. Drugs inhibiting the synthesis of lipid mediators or their effects, such as leukotriene synthesis inhibitors, leukotriene receptors antagonists, and more recently prostaglandin D-2 receptor antagonists, have been shown to modulate features of asthma and allergic diseases. This review, produced by an European Academy of Allergy and Clinical Immunology (EAACI) task force, highlights our current understanding of eicosanoid biology and its role in mediating human pathology, with a focus on new findings relevant for clinical practice, development of novel therapeutics, and future research opportunities.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30225 - Allergy
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
ALLERGY
ISSN
0105-4538
e-ISSN
1398-9995
Volume of the periodical
76
Issue of the periodical within the volume
1
Country of publishing house
US - UNITED STATES
Number of pages
17
Pages from-to
114-130
UT code for WoS article
000605369400007
EID of the result in the Scopus database
2-s2.0-85089338536